Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice (Q68074352)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

title

Interleukin 2 receptor targeted fusion toxin (DAB486-IL-2) treatment blocks diabetogenic autoimmunity in non-obese diabetic mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

author name string

Pacheco-Silva A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Bastos MG

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Muggia RA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Pankewycz O

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Nichols J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Murphy JR

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Strom TB

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

Rubin-Kelley VE

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1547815

7 October 2022

publication date

1 March 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

21 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

page(s)

697-702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

21 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Breeding of a non-obese, diabetic strain of mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Anti-α/β T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Pancreatic islet-specific T-cell clones from nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Interleukin-2: inception, impact, and implications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Interleukin 2 high-affinity receptor expression requires two distinct binding proteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

An explanation for the protective effect of the MHC class II I–E molecule in murine diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Delay in onset of insulitis in NOD mice following a single injection of CD 4 and CD8 antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Preventive effects of cyclosporin on diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830220312

7 January 2021

Identifiers

DOI

10.1002/EJI.1830220312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1547815%20AND%20SRC:MED&resulttype=core&format=json

21 September 2019

1 reference